FDC | PROCTER & GAMBLE HEALTH | FDC/ PROCTER & GAMBLE HEALTH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 25.0 | 34.5 | 72.5% | View Chart |
P/BV | x | 3.7 | 10.5 | 34.7% | View Chart |
Dividend Yield | % | 0.0 | 2.0 | - |
FDC PROCTER & GAMBLE HEALTH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
FDC Mar-23 |
PROCTER & GAMBLE HEALTH Jun-23 |
FDC/ PROCTER & GAMBLE HEALTH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 318 | 5,366 | 5.9% | |
Low | Rs | 229 | 3,883 | 5.9% | |
Sales per share (Unadj.) | Rs | 107.5 | 740.7 | 14.5% | |
Earnings per share (Unadj.) | Rs | 11.7 | 138.2 | 8.5% | |
Cash flow per share (Unadj.) | Rs | 14.0 | 155.2 | 9.0% | |
Dividends per share (Unadj.) | Rs | 0 | 95.00 | 0.0% | |
Avg Dividend yield | % | 0 | 2.1 | 0.0% | |
Book value per share (Unadj.) | Rs | 119.5 | 447.6 | 26.7% | |
Shares outstanding (eoy) | m | 165.91 | 16.60 | 999.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 2.5 | 6.2 | 40.7% | |
Avg P/E ratio | x | 23.4 | 33.5 | 70.0% | |
P/CF ratio (eoy) | x | 19.5 | 29.8 | 65.4% | |
Price / Book Value ratio | x | 2.3 | 10.3 | 22.2% | |
Dividend payout | % | 0 | 68.7 | 0.0% | |
Avg Mkt Cap | Rs m | 45,368 | 76,761 | 59.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 3,909 | 2,062 | 189.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 17,838 | 12,296 | 145.1% | |
Other income | Rs m | 512 | 184 | 278.6% | |
Total revenues | Rs m | 18,350 | 12,480 | 147.0% | |
Gross profit | Rs m | 2,496 | 3,247 | 76.9% | |
Depreciation | Rs m | 389 | 281 | 138.6% | |
Interest | Rs m | 41 | 8 | 530.8% | |
Profit before tax | Rs m | 2,578 | 3,142 | 82.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 640 | 847 | 75.5% | |
Profit after tax | Rs m | 1,938 | 2,295 | 84.5% | |
Gross profit margin | % | 14.0 | 26.4 | 53.0% | |
Effective tax rate | % | 24.8 | 27.0 | 92.0% | |
Net profit margin | % | 10.9 | 18.7 | 58.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 14,431 | 11,713 | 123.2% | |
Current liabilities | Rs m | 7,296 | 6,791 | 107.4% | |
Net working cap to sales | % | 40.0 | 40.0 | 99.9% | |
Current ratio | x | 2.0 | 1.7 | 114.7% | |
Inventory Days | Days | 265 | 263 | 100.8% | |
Debtors Days | Days | 251 | 343 | 73.1% | |
Net fixed assets | Rs m | 17,347 | 10,617 | 163.4% | |
Share capital | Rs m | 166 | 166 | 99.9% | |
"Free" reserves | Rs m | 19,655 | 7,265 | 270.6% | |
Net worth | Rs m | 19,820 | 7,431 | 266.7% | |
Long term debt | Rs m | 6 | 0 | - | |
Total assets | Rs m | 31,796 | 22,330 | 142.4% | |
Interest coverage | x | 64.1 | 409.1 | 15.7% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0.6 | 101.9% | |
Return on assets | % | 6.2 | 10.3 | 60.4% | |
Return on equity | % | 9.8 | 30.9 | 31.7% | |
Return on capital | % | 13.2 | 42.4 | 31.2% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 8.5 | 13.1 | 64.8% | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 1,509 | 1,605 | 94.0% | |
Fx inflow | Rs m | 3,259 | 1,465 | 222.4% | |
Fx outflow | Rs m | 1,509 | 1,605 | 94.0% | |
Net fx | Rs m | 1,749 | -140 | -1,247.7% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,549 | 2,360 | 65.6% | |
From Investments | Rs m | 111 | -215 | -51.8% | |
From Financial Activity | Rs m | -1,800 | -985 | 182.7% | |
Net Cashflow | Rs m | -138 | 1,160 | -11.9% |
Indian Promoters | % | 69.7 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 51.8 | - | |
Indian inst/Mut Fund | % | 9.6 | 20.0 | 48.0% | |
FIIs | % | 2.7 | 6.2 | 42.5% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 30.3 | 48.2 | 63.0% | |
Shareholders | 52,377 | 56,778 | 92.2% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare FDC With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | FDC | Procter & Gamble Health | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.20% | 0.23% | -0.57% |
1-Month | 5.55% | -1.43% | 0.07% |
1-Year | 48.13% | 0.31% | 52.18% |
3-Year CAGR | 13.21% | -9.37% | 14.04% |
5-Year CAGR | 22.23% | 4.58% | 19.13% |
* Compound Annual Growth Rate
Here are more details on the FDC share price and the Procter & Gamble Health share price.
Moving on to shareholding structures...
The promoters of FDC hold a 69.7% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of FDC and the shareholding pattern of Procter & Gamble Health.
Finally, a word on dividends...
In the most recent financial year, FDC paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
Procter & Gamble Health paid Rs 95.0, and its dividend payout ratio stood at 68.7%.
You may visit here to review the dividend history of FDC, and the dividend history of Procter & Gamble Health.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended the higher.